Prostate biopsy in Central Europe: Results of a survey of indication, patient preparation and biopsy technique

Urologia Internationalis

Volumn 79, Issue 1, 2007, Pages 60-66

  Fink, Klaus G ^a,c   Schmid, Hans Peter ^b   Paras, Ljiljana ^a   Schmeller, Nikolaus T ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b Kantonsspital St Gallen Klinik fur Urologie   (Switzerland)

^c Salzburger Landeskliniken   (Austria)

Author keywords

Cancer detection; Prostate biopsy; Prostate cancer

Indexed keywords

ANALGESIC AGENT; LIDOCAINE; PROSTATE SPECIFIC ANTIGEN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANALYTIC METHOD; ARTICLE; BIOPSY TECHNIQUE; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; EUROPE; HEALTH SURVEY; HUMAN; INFORMED CONSENT; LOCAL ANESTHESIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE BIOPSY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 34447330137     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102916     Document Type: Article

References (26)

1. Hodge KK, McNeal JE, Terris MK, Stamey TA: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-74.
2. Davis M, Sofer M, Kim SS, Soloway MS: The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol 2002;167:566-570.
3. Catalona WJ, Richie JP, Ahmann FR, et al: Comparison of digital rectal examination and serum prostate specific antigen in early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283-1290.
4. Catalona WJ, Ramos CG, Carvalhal GF, Yan Y: Lowering PSA cutoffs to enhance detection of curable prostate cancer. Urology 2000;55:791-795.
5. Schröder FH, Roobol-Bouts M, Vis AN, van der Kwast T, Kranse R: Prostate specific antigen based early detection of prostate cancer - Validation of screening without digital rectal examination. Urology 2001;57:83-90.
6. Oesterling JE, Jacobsen SJ, Cooner WH: The use of age specific reference ranges for serum prostate specific antigen in men 60 years or older. J Urol 1995;153:1160-1163.
7. Reissigl A, Horninger W, Fink K, Klocker H, Bartsch G: Prostate carcinoma screening in the county of Tyrol, Austria. Cancer 1997;80:1818-1829.
8. Catalona WJ, Smith DS, Ornstein DK: Prostate cancer detection in men with serum concentrations of 2.6 to 4.0 ng/ml and benign prostate examination: enhancement of specificity with free PSA measurements. JAMA 1997;277:1452-1455.
9. Akadas A, Cevik I, Turkeri L, Dalaman G, Emerk K: The role of free prostate specific antigen in the diagnosis of prostate cancer. Br J Urol 1997;79:920-923.
10. Reissigl A, Klocker H, Pointner J, et al: Usefulness of the ratio free/total PSA in addition to total PSA levels in prostate cancer screening. Urology 1996;48:62-66.
11. Lindert KA, Kabalin JN, Terris MK: Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 2000;164:76-80.
12. Sieber PR, Rommel FM, Agusta VE, et al: Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 1997;157:2199-2200.
13. Taylor HM, Bingham JB: The use of prophylactic antibiotics in ultrasound guided transrectal prostate biopsy. Clin Radiol 1997;52:787-790.
14. De Sio M, D'Armiento M, Di Lorenzo G, et al: The need to reduce patient discomfort during transrectal ultrasonography guided prostate biopsy: what do we know? BJU Int 2005;96:977-983.
15. Aus G, Abbou CC, Bolla M, et al: EAU guidelines on prostate cancer. Eur Urol 2005;48:546-551.
16. Desgrandchamps F, Meria P, Irani J, Desgrippes A, Teillac P, Le Duc A: The rectal administration of lidocaine gel and tolerance of transrectal ultrasonography guided biopsy of the prostate: a prospective randomized placebo controlled study. BJU Int 1999;83:1007-1009.
17. Chang SS, Alberts G, Wells N, et al: Intrarectal lidocaine during transrectal prostate biopsy: results of a prospective double-blind randomized trial. J Urol 2001;166:2178-2180.
18. Fink KG, Gnad A, Meissner P, et al: Lidocaine suppositories for prostate biopsy. BJU Int 2005;96:1028-1030.
19. Issa MM, Bux S, Chun T, et al: A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: the Emory University experience. J Urol 2000;164:397-399.
20. Terris MK: Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: preliminary report. Urology 1999;54:486-489.
21. Fink KG, Hutarew G, Lumper W, Jungwirth A, Dietze O, Schmeller NT: Prostate cancer detection with two sets of ten cores in comparison to two sets of sextant biopsies. Urology 2001;58:735-739.
22. Chen ME, Troncoso P, Johnston DA, Tang K, Babaian RJ: Optimization of prostate biopsy strategy using computer based analysis. J Urol 1997;158:2168-2175.
23. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P: Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 2000;89:1800-1809.
24. Peyromaure M, Ravery V, Boccon-Gibod L: The role of the biopsy of the transitional zone and of the seminal vesicles in the diagnosis and staging of prostate cancer. Eur Urol 2002;1:40-46.
25. Fink KG, Hutarew G, Pytel A, et al: Evaluation of transition zone and lateral sextant biopsies for prostate cancer detection after initial sextant biopsy. Urology 2003;61:748-753.
26. Stewart CS, Leibovich BC, Weaver AL, Lieber MM: Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001;166:86-92.